Human genomic diversity, viral genomics and proteomics, as exemplified by human papillomaviruses and H5N1 influenza viruses.
The diversity of hosts, pathogens and host-pathogen relationships reflects the influence of selective pressures that fuel diversity through ongoing interactions with other rapidly evolving molecules in the environment. This paper discusses specific examples illustrating the phenomenon of diversity of hosts and pathogens, with special reference to human papillomaviruses and H5N1 influenza viruses. We also review the influence of diverse host-pathogen interactions that determine the pathophysiology of infections, and their responses to drugs or vaccines.
Sakharkar
Meena K
MK
Biomedical Engineering Research Centre, Nanyang Technological University, Singapore.
Sakharkar
Kishore R
KR
Chow
Vincent T K
VT
D015894:Genome, Human; D016679:Genome, Viral; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000235:genetics*; D027383:Papillomaviridae / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D040901:Proteomics; D014764:Viral Proteins / Q000235:genetics*
D014764:Viral Proteins
J Proteome Res. 2006 Aug;5(8):1829-42
16889404
Annu Rev Biomed Eng. 2007;9:289-320
17391067
Ann Acad Med Singap. 2008 Jun;37(6):451-3
18618054
Bioinformatics. 2007 Sep 1;23(17):2337-8
17599940
Clin Pharmacol Ther. 2007 Mar;81(3):328-45
17339863
Gynecol Oncol. 2008 May;109(2 Suppl):S15-21
18474288
Annu Rev Genomics Hum Genet. 2001;2:9-39
11701642
Clin Pharmacokinet. 2006;45(3):253-85
16509759
J Pathol. 2006 Jan;208(2):152-64
16362994
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4473-8
17360548
J Clin Oncol. 2006 May 10;24(14):2151-7
16682733
Bioinformatics. 2007 Aug 15;23(16):2046-53
17545177
Virus Genes. 2007 Jun;34(3):283-7
16924425
EMBO J. 1987 Dec 1;6(12):3735-43
2828035
J Clin Microbiol. 1991 Sep;29(9):1765-72
1663516
Pharmacogenomics J. 2001;1(1):6-9
11913729
J Clin Endocrinol Metab. 2007 Jul;92(7):2590-7
17595259
Invest Ophthalmol Vis Sci. 1999 Jan;40(1):3-11
9888420
Nature. 1999 Apr 15;398(6728):545-6
10217129
Curr Pharm Biotechnol. 2003 Dec;4(6):351-78
14683431
J Am Board Fam Pract. 2001 Jul-Aug;14(4):266-73
11458969
Pharmacogenomics. 2006 Apr;7(3):311-29
16610942
Biophys J. 2007 Mar 1;92(5):1439-56
17158572
Pharmacogenomics J. 2001;1(3):167-70
11908751
Genome Res. 2001 Jun;11(6):927-9
11381021
Vitam Horm. 2004;69:271-95
15196886
Hum Mutat. 2001 Apr;17(4):263-70
11295823
J Clin Microbiol. 1996 Apr;34(4):802-9
8815087
Genome Biol. 2003;4(11):R72
14611658
Annu Rev Pharmacol Toxicol. 2001;41:101-21
11264452
Nature. 2005 Oct 27;437(7063):1299-320
16255080
Virology. 2004 Jun 20;324(1):17-27
15183049
Virology. 2003 May 25;310(1):100-8
12788634
J Gen Virol. 1999 Nov;80 ( Pt 11):2923-2929
10580054
Int J Biochem Cell Biol. 2007;39(6):1156-64
17446117
J Virol. 2003 Mar;77(5):2819-31
12584305
J Virol. 1992 Apr;66(4):2057-66
1312620
J Virol. 2005 Jun;79(11):6732-40
15890911
Gene. 1999 Jul 8;234(2):177-86
10395891
Virology. 1998 Jan 20;240(2):359-65
9454709
Microbes Infect. 2009 Jan;11(1):2-11
18983930
EMBO J. 1991 Feb;10(2):449-57
1846806
Expert Opin Drug Saf. 2005 Jan;4(1):103-28
15709902
Nature. 2005 Oct 27;437(7063):1241-2
16251937